<unk>  is a thrombopoietin receptor agonist that is FDA approved for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include thrombocytopenia, aplastic anemia, hyperbilirubinemia, fatigue, cough, epistaxis, fever, diarrhea.
Eltrombopag
Avatrombopag
Lusutrombopag
Reteplase
Otamixaban
Ximelagatran
Hirudin
Anistreplase